Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment

Immunity

Volumn 6, Issue 3, 1997, Pages 315-325

  Romano, Maria ^a   Sironi, Marina ^a   Toniatti, Carlo ^b   Polentarutti, Nadia ^a   Fruscella, Paolo ^a   Ghezzi, Pietro ^a   Faggioni, Raffaella ^a   Luini, Walter ^a   Van Hinsbergh, Victor ^d   Sozzani, Silvano ^a   Bussolino, Federico ^c   Poli, Valeria ^b   Ciliberto, Gennaro ^b   Mantovani, Alberto ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b IRBM   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; ENDOTHELIUM CELL; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030891228     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80334-9     Document Type: Article

References (71)

1. Aderka, D., Le, J.M., and Vilcek, J. (1989). IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143, 3517-3523.
2. Aggarwal, B.B., Kohr, W.J., Hass, P.E., Moffat, B., Spencer, S.A., Henzel, W.J., Bringman, T.S., Nedwin, G.E., Goeddel, D.V., and Harkins, R.N. (1985). Human tumor necrosis factor: production, purification, and characterization. J. Biol. Chem. 260, 2345-2354.
3. Akira, S., Nishio, Y., Inoue, M., Wang, X.J., Wei, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., and Kishimoto, T. (1994). Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71.
4. Allavena, P., Paganin, C., Martin Padura, I., Peri, G., Gaboli, M., Dejana, E., Marchisio, P.C., and Mantovani, A. (1991). Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J. Exp. Med. 173, 439-448.
5. Andert, S.E., Griesmacher, A., Zuckermann, A., and Muller, M.M. (1992). Neopterin release from human endothelial cells is triggered by interferon-γ. Clin. Exp. Immunol. 88, 555-558.
6. Arbo, A., Mancilla, J., Alpuche, C., and Santos, J.I. (1990). In vitro and in vivo effects of subinhibitory concentrations of clindamycin on experimental Klebsiella pneumoniae sepsis. Chemotherapy 36, 337-344.
7. Barton, B.E., and Jackson, J.V. (1993). Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 61, 1496-1499.
8. Barut, B., Chauhan, D., Uchiyama, H., and Anderson, K.C. (1993). Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro. J. Clin. Invest. 92, 2346-2352.
9. Biondi, A., Rossi, V., Bassan, R., Barbui, T., Bettoni, S., Sironi, M., Mantovani, A., and Rambaldi, A. (1989). Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73, 1279-1284.
10. Boetcher, D.A., and Meltzer, M.S. (1975). Mouse mononuclear cell chemotaxis: description of system. J. Natl. Cancer Inst. 54, 795-799.
11. Brown, T.J., Rowe, J.M., Liu, J.W., and Shoyab, M. (1991). Regulation of IL-6 expression by oncostatin M. J. Immunol. 147, 2175-2180.
12. Bussolino, F., Camussi, G., and Baglioni, C. (1988). Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1α. J. Biol. Chem. 263, 11856-11861.
13. Campbell, I.L., Abraham, C.R., Masliah, E., Kemper, P., Inglis, J.D., Oldstone, M.B., and Mucke, L. (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061-10065.
14. Campbell, I.L., Hobbs, M.V., Dockter, J., Oldstone, M.B., and Allison, J. (1994). Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am. J. Pathol. 145, 157-166.
15. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. (1979). Isolation of a biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5300.
16. Colotta, F., Sironi, M., Borre, A., Luini, W., Maddalena, F., and Mantovani, A. (1992). Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells. Cytokine 4, 24-28.
17. Dalrymple, S.A., Lucian, L.A., Slattery, R., McNeil, T., Hud, D.M., Fuchino, S., Lee, F., and Murray, R. (1995). Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63, 2262-2268.
18. De Benedetti, F., Massa, M., Pignatti, P., Albani, S., Novick, D., and Martini, A. (1994). Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J. Clin. Invest. 93, 2114-2119.
19. Dejana, E., Breviario, F., Erroi, A., Bussolino, F., Mussoni, L., Gramse, M., Pintucci, G., Casali, B., Dinarello, C.A., Van Damme, J., et al. (1987). Modulation of endothelial cell functions by different molecular species of interleukin 1. Blood 69, 695-699.
20. Di Cosmo, B.F., Picarella, D., and Flavell, R.A. (1994). Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice. Int. Immunol. 6, 1829-1837.
21. Edwards, J.C., Sedgwick, A.D., and Willoughby, D.A. (1981). The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134, 147-156.
22. Fantuzzi, G., and Dinarello, C.A. (1996). The inflammatory response in interleukin-1β-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukoc. Biol. 59, 489-493.
23. Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., and Poli, V. (1994). Defective inflammatory response in IL-6 deficient mice. J. Exp. Med. 180, 1243-1250.
24. Frieling, J.T., van Deuren, M., Wijdenes, J., van der Meer, J.W., Clement, C., van der Linden, C.J., and Sauerwein, R. W. (1995). Circulating interleukin-6 receptor in patients with sepsis syndrome. J. Infect. Dis. 171, 469-472.
25. Furutani, Y., Nomura, H., Notake, M., Oyamada, Y., Fukuy, T., Yamada, M., Larsen, C.G., Oppenheim, J.J., and Matsushima, K. (1989). Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem. Biophys. Res. Commun. 159, 248-255.
26. Gaillard, J.P., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T., and Klein, B. (1993). Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur. J. Immunol. 23, 820-824.
27. Ghigo, D., Arese, M., Todde, R., Vecchi, A., Silvagno, F., Costamagna, C., Dong, Q.G., Alessio, M., Heller, R., Soldi, R., et al. (1995). Middle Tantigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase. J. Exp. Med. 181, 9-19.
28. Hirano, T., Akira, S., Taga, T., and Kishimoto, T. (1990). Biological and clinical aspects of interleukin 6. Immunol. Today 11, 443-449.
29. Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Osugi, Y., Tokunaga, T., and Kishimoto, T. (1992). Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148, 2175-2180.
30. Howells, G., Pham, P., Taylor, D., Foxwell, B., and Feldmann, M. (1991). Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-γ. Eur. J. Immunol. 21, 97-101.
31. Introna, M., Breviario, F., D'Aniello, E., Golay, J., Dejana, E., and Mantovani, A. (1993). IL-1 inducible genes in human umbilical vein endothelial cells. Eur. Heart J. 14 (suppl. K), 78-81.
32. Jirik, F.R., Podor, T.J., Hirano, T., Kishimoto, T., Loskutoff, D.J., Carson, D.A., and Lotz, M. (1989). Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142, 144-147.
33. Jonjic, N., Peri, G., Bernasconi, S., Sciacca, F.L., Colotta, F., Pelicci, P., Lanfrancone, L., and Mantovani, A. (1992). Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J. Exp. Med. 176, 1165-1174.
34. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988). Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332, 83-85.
35. Kishimoto, T., Taga, T., and Akira, S. (1994). Cytokine signal transduction. Cell 76, 253-262.
36. Kishimoto, T., Akira, S., Narazaki, M., and Taga, T. (1995). Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
37. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G. (1994). Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.
38. Luini, W., Sozzani, S., Van Damme, J., and Mantovani, A. (1994). Species-specificity of monocyte chemotactic protein-1 and -3. Cytokine 6, 28-31.
39. Lust, J.A., Donovan, K.A., Kline, M.P., Greipp, P.R., Kyle, R.A., and Maihle, N.J. (1992). Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4, 96-100.
40. Mantovani, A., Bussolino, F., and Dejana, E. (1992). Cytokine regulation of endothelial cell function. FASEB J. 6, 2591-2599.
41. Martich, G.D., Danner, R.L., Ceska, M., and Suffredini, A.F. (1991). Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J. Exp. Med. 173, 1021-1024.
42. Miles, S.A., Rezai, A.R., Salazar Gonzalez, J.F., Vander Meyden, M., Stevens, R.H., Logan, D.M., Mitsuyasu, R.T., Taga, T., Hirano, T., Kishimoto, T., et al. (1990). AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA 87, 4068-4072.
43. Minty, A., Chalon, P., Guillemot, J.C., Kaghad, M., Liauzun, P., Magazin, M., Miloux, B., Minty, C., Ramond, P., Vita, N., Lupker, J., Shire, D., Ferrara, P., and Caput, D. (1993). Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur. Cytokine Netw. 4, 99-110.
44. Motro, B., Itin, A., Sachs, L., and Keshet, E. (1990). Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci. USA 87, 3092-3096.
45. Mullberg, J., Schooltink, H., Stoyan, T., Gunther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P.C., and Rose John, S. (1993). The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23, 473-480.
46. Novick, D., Engelmann, H., Wallach, D., and Rubinstein, M. (1989). Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170, 1409-1414.
47. Opdenakker, G., Froyen, G., Fiten, P., Proost, P., and Van Damme, J. (1993). Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem. Biophys. Res. Commun. 191, 535-542.
48. Peri, G., Milanese, C., Matteucci, C., Ruco, L., Zhou, D., Sozzani, S., Coletta, I., and Mantovani, A. (1994). A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines: development of a sandwich ELISA and in situ detection of producing cells. J. Immunol. Meth. 174, 249-257.
49. Pober, J., and Cotran, R.S. (1990). Cytokines and endothelial cell biology. Physiol. Rev. 70, 427-451.
50. Podor, T.J., Jirik, F.R., Loskutoff, D.J., Carson, D.A., and Lotz, M. (1989). Human endothelial cells produce IL-6: lack of responses to exogenous IL-6. Ann. NY Acad. Sci. 557, 374-385.
51. Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G.A., and Costantini, F. (1994). Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189-1196.
52. Rollins, B.J., and Pober, J.S. (1991). Interleukin-4 induces the synthesis and secretion of MCP-1JE by human endothelial cells. Am. J. Pathol. 138, 1315-1319.
53. Rollins, B.J., Yoshimura, T., Leonard, E.J., and Pober, J.S. (1990). Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am. J. Pathol. 136, 1229-1233.
54. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183, 1345-1355.
55. Salvati, A.L., Lahm, A., Paonessa, G., Ciliberto, G., and Toniatti, C. (1995). Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor α mutated in the predicted gp130-binding interface. J. Biol. Chem. 270, 12242-12249.
56. Savino, R., Ciapponi, L., Lahm, A., Demartis, A., Cabibbo, A., Toniatti, C., Delmastro, P., Altamura, S., and Ciliberto, G. (1994). Rational design of a receptor super-antagonist of human interleukin-6. EMBO J. 13, 5863-5870.
57. Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S.C., and Dinarello, C.A. (1990). Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75, 40-47.
58. Schwab, G., Siegall, C.B., Aarden, L.A., Neckers, L.M., and Nordan, R.P. (1991). Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood 77, 587-593.
59. Shalaby, M.R., Waage, A., and Espevik, T. (1989). Cytokine regulation of interleukin 6 production by human endothelial cells. Cell. Immunol. 121, 372-382.
60. Sica, A., Wang, J.M., Colotta, F., Dejana, E., Mantovani, A., Oppenheim, J.J., Larsen, C.G., Zachariae, C.O., and Matsushima, K. (1990). Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J. Immunol. 144, 3034-3038.
61. Sin, Y.M., Tan, C.H., and Chan, S.F. (1989). Changes in histamine and prostaglandins in acute inflammatory air pouch in mice. Agents Actions 28, 98-102.
62. Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E., and Mantovani, A. (1989). IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142, 549-553.
63. Sironi, M., Sciacca, F.L., Matteucci, C., Conni, M., Vecchi, A., Bernasconi, S., Minty, A., Caput, D., Ferrara, P., Colotta, F., and Mantovani, A. (1994). Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84, 1913-1921.
64. Sporeno, E., Paonessa, G., Salvati, A.L., Graziani, R., Delmastro, P., Ciliberto, G., and Toniatti, C. (1994). Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. J. Biol. Chem. 269, 10991-10995.
65. Sporeno, E., Savino, R., Ciapponi, L., Cabibbo, A., Lahm, A., Pulkki, K., Sun, R.-X., Toniatti, C., Klein, B., and Ciliberto, G. (1996). Human IL-6 receptor superantagonists with high potency and wide spectrum on multiple myeloma cells. Blood 87, 4510-4519.
66. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., and Kishimoto, T. (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361.
67. Toniatti, C., Cabibbo, A., Sporeno, E., Salvati, A.L., Cerretani, M., Serafini, S., Lahm, A., Cortese, R., and Ciliberto, G. (1996). Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity. EMBO J. 15, 2726-2737.
68. Van Hinsbergh, V.W.M., Sprengers, E.D., and Kooistra, T. (1987). Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb. Haemost. 57, 148-153.
69. Vink, A., Coulie, P., Warnier, G., Renauld, J.C., Stevens, M., Donckers, D., and Van Snick, J. (1990). Mouse plasmacytoma growth in vivo: enhancement by interleukin-6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J. Exp. Med. 172, 997-1000.
70. Yan, S.F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., and Stern, D. (1995). Induction of interleukin 6 (IL-6) by hypoxia in vascular cells: central role of the binding site for nuclear factor-IL-6. J. Biol. Chem. 270, 11463-11471.
71. Zhong, Z., Wen, Z., and Darnell, J.E.J. (1994). Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95-98.